Skip to content

Mindfulness-Based Yoga in Schizophrenia

The Effect of Mindfulness-Based Yoga on Psychological Well-Being and Happiness in Individuals With Schizophrenia: A Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07497516
Acronym
MBY-SCZ
Enrollment
91
Registered
2026-03-27
Start date
2024-02-01
Completion date
2024-08-01
Last updated
2026-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SCHIZOPHRENIA 1 (Disorder)

Keywords

Schizophrenia Mindfulness Yoga Mindfulness-Based Yoga Psychological Well-Being Happiness Randomized Controlled Trial

Brief summary

This randomized controlled trial aimed to evaluate the effect of mindfulness-based yoga on psychological well-being and happiness in individuals diagnosed with schizophrenia. Participants were recruited from community mental health centers and randomly assigned to either an intervention group or a control group. The intervention group participated in a structured mindfulness-based yoga program consisting of 12 sessions over six weeks, including mindfulness practices, breathing exercises, meditation, and yoga postures. The control group received routine care without additional intervention. Primary outcomes included psychological well-being and happiness, measured using validated scales at baseline and post-intervention. The findings of the study are expected to contribute to the development of psychosocial interventions that support mental health and well-being in individuals with schizophrenia.

Interventions

A structured mindfulness-based yoga program consisting of 12 sessions delivered over 6 weeks. The program includes mindfulness practices, breathing exercises, meditation, and yoga postures conducted in group sessions.

Sponsors

Tarsus University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosed with schizophrenia according to DSM-5 criteria * Aged between 18 and 65 years * Willing to participate in the study * Able to provide informed consent

Exclusion criteria

* Being in an acute exacerbation phase of schizophrenia * Participation in mindfulness or yoga training within the last 6 months * Presence of comorbid neurological or cognitive disorders (e.g., dementia, delirium, intellectual disability, or history of head trauma) * Current substance use

Design outcomes

Primary

MeasureTime frameDescription
Psychological Well-BeingBaseline and 6 weeks (post-intervention)Psychological well-being will be assessed using the Psychological Well-Being Scale (PWB), a validated self-report instrument consisting of 8 items rated on a 7-point Likert scale. Higher scores indicate greater psychological well-being.
HappinessBaseline and 6 weeks (post-intervention)Happiness will be assessed using the Oxford Happiness Questionnaire Short Form (OHQ-SF), a validated self-report scale. Higher scores indicate greater levels of happiness.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026